Trevor McFarland

This inventor holds 8 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Research Development Foundation, Oregon Health & Science University. Active years: 2009-2021.

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 25.0

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 9(Granted Patents)

Company Filing History:

7 out of 299

Research Development Foundation

patents

3 out of 524

Oregon Health & Science University

patents

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098097 - Recombinant filaggrin polypeptides for cell importation (2021-08-24),

2. 10336797 - Recombinant filaggrin polypeptides for cell importation (2019-07-02),

3. 9937269 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2018-04-10),

4. 9650426 - RTEF-1 variants and uses thereof (2017-05-16),

5. 9512423 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2016-12-06),

6. 8785385 - RTEF-1 variants and uses thereof (2014-07-22),

7. 8748379 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2014-06-10),

8. 7557197 - Human soluble neuropilin-1 primary polyadenylation signal and uses thereof (2009-07-07),

Title: The Innovative Contributions of Trevor McFarland

Introduction

Trevor McFarland is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 8 patents to his name, McFarland's work has the potential to impact the treatment of skin diseases and disorders.

Latest Patents

One of McFarland's latest patents focuses on recombinant filaggrin polypeptides for cell importation. This invention discloses recombinant polypeptides that include a filaggrin amino acid sequence and a cell importation signal sequence. The signal sequence contains a motif of two to fifteen amino acids, which includes at least one arginine residue and at least one methionine residue. Additionally, the patent covers nucleic acids encoding these recombinant polypeptides, as well as compositions that incorporate them. The methods outlined in this patent aim to treat or prevent skin diseases or disorders using the described compositions, along with kits that contain the recombinant polypeptides.

Career Highlights

Throughout his career, Trevor McFarland has worked with esteemed organizations such as the Research Development Foundation and Oregon Health & Science University. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to advancements in medical research.

Collaborations

Some of McFarland's notable coworkers include J Timothy Stout and Binoy Appukuttan. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Trevor McFarland's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of skin diseases and disorders.